When Anti-VEGF Agents Don’t Work: Using Intravitreal Steroids Alone or in Combination to Treat DME/DR - A Woman With Longstanding Diabetes Presents With Decreased Vision

When Anti-VEGF Agents Don’t Work: Using Intravitreal Steroids Alone or in Combination to Treat DME/DR - A Woman With Longstanding Diabetes Presents With Decreased Vision is organized by Paradigm Medical Communications, LLC.

Release Date: April 30, 2019
Expiration Date: April 30, 2020

Accreditation:
Physician Credit Designation Statement:
Global Education Group designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Continuing Education:
PAs may claim a maximum of 0.25 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Learning Objectives:
Upon proper completion of this activity, participants should be better able to:
• Identify how key elements of inflammatory-mediated mechanisms and angiogenesis-mediated mechanisms work together in the pathophysiology of DME and DR
• Describe how the mechanisms of action of anti-VEGF agents and intravitreal steroids target inflammation and angiogenesis pathways in patients with DME and DR
• Develop treatment strategies for patients with DME and DR using intravitreal steroids alone or in combination with anti-VEGF treatments, based on current clinical data

Additional details will be posted as soon as information is available.